Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

LENZ

LENZ Therapeutics (LENZ)

LENZ Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:LENZ
日付受信時刻ニュースソース見出しコード企業名
2024/11/1222 : 00GlobeNewswire Inc.LENZ Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:LENZLENZ Therapeutics Inc
2024/11/0621 : 00GlobeNewswire Inc.LENZ Therapeutics Reports Third Quarter 2024 Financial ResultsNASDAQ:LENZLENZ Therapeutics Inc
2024/10/3021 : 00GlobeNewswire Inc.LENZ Therapeutics to Report Third Quarter Financial Results and Business Update on November 6, 2024NASDAQ:LENZLENZ Therapeutics Inc
2024/10/2810 : 00GlobeNewswire Inc.CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100NASDAQ:LENZLENZ Therapeutics Inc
2024/10/2121 : 00GlobeNewswire Inc.LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of PresbyopiaNASDAQ:LENZLENZ Therapeutics Inc
2024/09/3021 : 00GlobeNewswire Inc.LENZ Therapeutics Announces Presentations at Upcoming Ophthalmology and Optometry Medical ConferencesNASDAQ:LENZLENZ Therapeutics Inc
2024/08/2805 : 01GlobeNewswire Inc.LENZ Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:LENZLENZ Therapeutics Inc
2024/08/1505 : 05GlobeNewswire Inc.LENZ Therapeutics Reports Second Quarter 2024 Financial ResultsNASDAQ:LENZLENZ Therapeutics Inc
2024/08/1221 : 00GlobeNewswire Inc.LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of PresbyopiaNASDAQ:LENZLENZ Therapeutics Inc
2024/08/0805 : 01GlobeNewswire Inc.LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024NASDAQ:LENZLENZ Therapeutics Inc
2024/07/1521 : 00GlobeNewswire Inc.LENZ Therapeutics Announces $30 Million Investment from Ridgeback CapitalNASDAQ:LENZLENZ Therapeutics Inc
2024/06/1021 : 00GlobeNewswire Inc.LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024NASDAQ:LENZLENZ Therapeutics Inc
2024/05/3021 : 00GlobeNewswire Inc.LENZ Therapeutics to Present at the Jefferies Global Healthcare ConferenceNASDAQ:LENZLENZ Therapeutics Inc
2024/05/2121 : 31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LENZLENZ Therapeutics Inc
2024/05/1005 : 18Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LENZLENZ Therapeutics Inc
2024/05/0906 : 11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LENZLENZ Therapeutics Inc
2024/05/0905 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LENZLENZ Therapeutics Inc
2024/05/0905 : 01GlobeNewswire Inc.LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:LENZLENZ Therapeutics Inc
2024/05/0205 : 01GlobeNewswire Inc.LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024NASDAQ:LENZLENZ Therapeutics Inc
2024/04/0320 : 00Business WireLENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia TrialsNASDAQ:LENZLENZ Therapeutics Inc
2024/04/0305 : 01Business WireLENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia TrialsNASDAQ:LENZLENZ Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:LENZ

最近閲覧した銘柄

Delayed Upgrade Clock